Cochrane · systematic review · CD009886
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection
Okwen, MP, Reid, S, Njei, B, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
HIV/AIDSAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
1
No studies
4
Included studies
NR
No studies 4 · 80%Ungraded 0 · 0%Very low 1 · 20%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Hepatitis B vaccination compared to placebo for reducing morbidity and mortality in persons with HIV infection
Population: Persons with HIV infection
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Hepatitis B Virus infection ‐ not measured Hepatitis B vaccination vs placebo | no estimate extracted | NR | No studies |
Hepatitis B virus morbidity ‐ not measured Hepatitis B vaccination vs placebo | no estimate extracted | NR | No studies |
Hepatitis B virus related mortality ‐ not measured Hepatitis B vaccination vs placebo | no estimate extracted | NR | No studies |
All cause mortality ‐ not measured Hepatitis B vaccination vs placebo | no estimate extracted | NR | No studies |
Hepatitis B antibody titre (IgG) Hepatitis B vaccination vs placebo | no estimate extracted | 1 study · 25 participants | Very low Downgraded: risk of bias, imprecision |